Compare Citius Pharmaceuticals Inc (CTXR) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Tempus AI — how do they compare? Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.83M), while Tempus AI trades at $58.73 (market cap $10.04B). The key difference: Tempus AI is far larger — about 677× Citius Pharmaceuticals Inc's market cap, and Tempus AI is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | TEM | |
|---|---|---|
Market Cap | $14.83M | $10.04B |
Sector | Health | Broad Market / Factor |
52-Week High | $1.82 | $103.25 |
52-Week Low | $0.53 | $42.37 |
Enterprise Value | $11.05M | $10.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
